ETERNITY BIOSCIENCE INC has a total of 45 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), China and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are CROOKS PETER A, ASCENEURON SA and XI NING.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 11 | |
#2 | China | 7 | |
#3 | Canada | 4 | |
#4 | Taiwan | 4 | |
#5 | United States | 4 | |
#6 | Mexico | 3 | |
#7 | Australia | 2 | |
#8 | Brazil | 2 | |
#9 | EPO (European Patent Office) | 2 | |
#10 | Hong Kong | 2 | |
#11 | Republic of Korea | 2 | |
#12 | Argentina | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Sugars | |
#7 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Liu Dong | 36 |
#2 | Zhang Minsheng | 35 |
#3 | Lu Biao | 10 |
#4 | He Feng | 10 |
#5 | Hu Qiyue | 10 |
#6 | Tao Weikang | 10 |
#7 | Liu Suxing | 9 |
#8 | Zhuang Linghang | 7 |
#9 | Zhang Rumin | 7 |
#10 | Yan Yinfa | 6 |
Publication | Filing date | Title |
---|---|---|
WO2020205538A1 | Cd73 inhibitors and therapeutic uses thereof | |
WO2020124059A1 | Tricyclic compounds as sting agonists, and preparation methods and medicinal uses thereof | |
WO2020047082A1 | Cd73 inhibitors and therapeutic uses thereof | |
CN112135611A | Benzimidazole derivatives as modulators of retinoic acid-related orphan receptor gamma (ROR γ) and pharmaceutical uses thereof | |
WO2018208727A1 | Nucleoside and nucleotide analogues as cd73 inhibitors and therapeutic uses thereof | |
US2017152264A1 | Aminopyridazinone compounds as protein kinase inhibitors | |
TW201506021A | Furanone compounds as kinase inhibitors | |
MX2015003196A | Aminoisoquinoline derivatives as protein kinase inhibitors. | |
WO2012125521A1 | Quinazolinediones and their use |